QualityStocksNewsBreaks Archives - Page 114 of 1421

FridaySep 06, 2024 11:25 am

QualityStocksNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) CEO to Present at Upcoming Morgan Stanley Conference

Lucid Group (NASDAQ: LCID), maker of the world’s most advanced electric vehicles, has announced that its CEO and CTO Peter Rawlinson will participate in a fireside chat at the Morgan Stanley 12th Annual Laguna Conference on Thursday, Sept. 12. According to the announcement, the session is scheduled to begin at 2:35 p.m. PT and will be webcast live on Lucid’s investor relations website. A replay of the webcast will be available for 60 days following the live presentation. To view the full press release, visit https://ibn.fm/MrbJU About Lucid Group Lucid is a Silicon Valley-based technology company focused on creating the…

ThursdaySep 05, 2024 11:15 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as New CEO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership, operations, acquisitions/licensing, business development, strategic planning and capital markets. Mr. Christopher takes over from outgoing CEO, Chris Bunka, who has stepped aside from the role. Mr. Bunka remains as the Chairman of the Board of Directors and has been appointed Executive Strategic Advisor to the…

ThursdaySep 05, 2024 10:49 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced participation at the H.C. Wainwright 26th Annual Global Investment Conference. The conference, held virtually and in person, is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel in New York City. According to the announcement, Maria L. Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, will deliver a 30-minute company presentation on Tuesday, September 10, 2024, at 8 a.m. ET. Later that day, at 2 p.m. ET., Dr. Maccecchini will take part in…

WednesdaySep 04, 2024 3:25 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO John Climaco will present at the event; his presentation will be available as an on-demand video webcast beginning Sept. 9 at 7 a.m. ET. Climaco will also be available to participate in one-on-one meetings. To view the on-demand webcast, visit https://ibn.fm/gaP8o To view the full…

WednesdaySep 04, 2024 12:54 pm

QualityStocksNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Reports Early Return on Investment at SASB Gas Field, Shares August Performance

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided a production update for the SASB gas field, noting that the SASB revitalization program realized the complete payback of recent perforation costs. According to the update, the Guluc-2, South Akcakoca-2, West Akcakoca-1 and Akcakoca-3 wells started production over a staggered period from July 9 to July 28 and have already produced 140MMcf, representing a 35-day payoff of the recent perforation CAPEX. Gas production from the Akcakoca platform has averaged 4.6 MMcf/d since the…

WednesdaySep 04, 2024 11:40 am

QualityStocksNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor

Telomir Pharmaceuticals (NASDAQ: TELO), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, today announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel’s extensive career in pharmaceutical innovation spans over 40 years, during which he has been instrumental in the research, development, and regulatory approvals of numerous therapies across various therapeutic areas. Dr. Angel will collaborate with Telomir’s senior management to expedite the pre-clinical and clinical path of Telomir-1, the company’s lead product candidate. According to the announcement, Dr. Angel will concentrate his scientific efforts on unveiling and experimentally…

WednesdaySep 04, 2024 11:03 am

QualityStocksNewsBreaks – WiSA Technologies, Inc. (NASDAQ: WISA) Executes Definitive Agreement to Create ‘Larger, More Dynamic Entity’ with Broad Reach

WiSA Technologies (NASDAQ: WISA) today announced the execution of a definitive asset purchase agreement to purchase the Datavault(R) intellectual property and information technology assets of privately held Data Vault Holdings Inc. WiSA will pay $210 million as consideration, consisting of 40 million shares of common stock to be issued at $5 per share plus a $10 million 3-year unsecured promissory note. The transaction is expected to close before December 31, 2024, subject to customary conditions and approvals. The purchase will create a publicly traded data technology and licensing company with an extensive patent portfolio serving multiple industries and government entities…

WednesdaySep 04, 2024 10:38 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Provides Update on Its Iska Iska Silver-Tin Polymetallic Project in Southwestern Bolivia

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, today provided an update on its Iska Iska silver-tin polymetallic project in Potosi Department, southern Bolivia. According to the update, an initial program of 5,700m of diamond drilling in 13 holes in the Santa Barbara starter pit area is planned to better define the vertical and lateral extent of high-grade Ag mineralization. This will be followed by an additional 1,400m in two larger PQ holes for further metallurgical testing in Sn mineralization to…

TuesdaySep 03, 2024 2:47 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Additional Orders from European Governments Totaling $2.6M

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has received new orders valued at $2.6 million from different governments in Europe; the company anticipates fulfilling the orders in the next three months. The company offers PureSecurity Suite, an end-to-end electronic monitoring solution that features state-of-the-art GPS tracking, communication and monitoring technologies, as well as a secure software platform providing real-time tracking and reporting. “We are delighted to continue strengthening our collaboration with European governments,” said SuperCom president and CEO Ordan Trabelsi in the press release. “These repeat orders underscore our customers' confidence…

TuesdaySep 03, 2024 12:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical company evaluating the pharmacokinetics of these compositions in animal studies. According to the company, Lexaria has awarded the pharmaceutical company a temporary exclusive license option limited to specific DehydraTECH concepts and formulations under examination. The work is expected to be completed within roughly 6 months…

Site Search

Company Search

Category: QualityStocksNewsBreaks